Nottingham's City Hospital haematology department manages myeloma and lymphoma patients requiring Bortezomib-based combination therapy. Bortenat 3.5mg injection vials provide identical treatment to brand Velcade at substantially reduced institutional cost for Nottingham procurement teams.
Bortezomib disrupts the proteasome pathway — the cellular recycling system that cancer cells rely on to remove damaged proteins. When this pathway is blocked, abnormal proteins accumulate inside myeloma and lymphoma cells, triggering cell death. Normal cells are more resistant to this effect, giving Bortezomib a useful therapeutic window.
Visit medshopy.com or WhatsApp +91 82650 41513 for institutional wholesale pricing.
Bortezomib disrupts the proteasome pathway — the cellular recycling system that cancer cells rely on to remove damaged proteins. When this pathway is blocked, abnormal proteins accumulate inside myeloma and lymphoma cells, triggering cell death. Normal cells are more resistant to this effect, giving Bortezomib a useful therapeutic window.
Visit medshopy.com or WhatsApp +91 82650 41513 for institutional wholesale pricing.